Investigator of highy potential publicly traded companies
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It’s official, Vegas it is! When we hit a buck, I’ll be taking names for the guest list. Now, let’s get back to work! See you guys in Vegas in November!!!!!
I think we will be trading around the .27 cent level by November this year. More going on then we realize.
You guys that are familiar with the .27 cent per share deal for Medistem, calculate what someone would have at the end of the transaction/buyout if an investor, at that time, bought a million shares at .02 and sat until the done deal. That would be interesting. Different outstanding share situation I guess...... tks
Excellent post!
Next week we will hit a high of .035. Watch. The weekend DD will bring more to the party. Chance of a lifetime folks.
Announcing the $1.00 bid Vegas Party at the Palms! Who is in??? Reply to this post if you are interested. When CELZ hits $1.00, that is the signal. Interested shareholders are celebrating in VEGAS BABY. AGREE??????? Sign up now because.... it.....will......be.........happening! Hello?
Best post ever on this board. Very well articulated! This synopsis says it all!!!!! We have a winner here peeps. I could have said it any better. That post is worth rereading again if you get discouraged and are thinking of selling. Go CELZ !!!!
These small price movements, a month from now, will be nothing and the chart will appear like a flatline around .02 cents. When this runs to $.15-$.22, people will wish they could time travel back to June and loading. Looking forward to the Caverstem campaign that will start up soon. Expecting to see Gershwin‘s face and patient interviews etc etc. So many press releases, it’s sick! This is a bad stock too short. Massive runner here coming up and it hasn’t even started yet.
Hey Room. Does anyone have any intel on the new sales guy Gary Mells? Who has he worked for? Sounds like a great fit. Intel???
This is a hidden secret on the OTCBB. President Warbington has positioned himself at around .014 cents on 10 mil shares. Urologists signing up, new novel stem cell treatments being rolled out. Legit as ever in comparison to some of the other pink/OTCBB companies. This will hit .02 within the first 5 minutes of trading tomorrow. By August I think the chart will reflect a share price and chart that has touched .25 cents. Do your dd before buying this stock! Great company with WORLD RENOWNED PHYSICIANS ON BOARD!!
It won’t take that long brother. Too many PR is in the hopper with too many technologies ready to come out. CaverStem alone will put it up over that Mark in short order. Just watch. This is going to get stupid.
Strong hold here. Heading back to a penny easily.
.045 on Tuesday?? According to the chart that could certainly occur + based on technicals and momo.
CEO Tim Warmington states “We are very fortunate to work with the expert team at Los Angeles Biomedical Institute - UCLA/Harbor Hospital who have done an outstanding job with subject recruitment, screening, treatment and follow-up. We firmly believe that we are on schedule for commercialization of the Caverstem TM procedure through publication and presentation of trial results, marketing, licensing, training and sales in 2018," said Timothy Warbington, President and CEO of Creative Medical Technology Holdings Inc.”
From: https://ceo.ca/@newswire/developments-in-the-erectile-dysfunction-markets
UCLA Trial CONCLUSION:
Bone marrow stem cell therapy has demonstrated thera- peutic effects in clinical trials of heart failure and ad- vanced peripheral artery disease. The rationale for bone marrow stem cell therapy of the penis in patients with erectile dysfunction is strong given that: a) The penile vasculature is the most endothelial-rich anatomical region of the body, thus even a small amount of therapeutic cells are likely to be incorporated; b) Blood flow in the flaccid penis is slower compared to systemic circulation, thus allowing for superior retention; and c) ease of injection given its external location. From an ethical perspective, the procedure of penile prosthesis implantation requires de- struction of the cavernous, thus making it irreversible. The feasibility of the injection procedure, the fact that no ad- verse effects were noted, and the ease of the procedure, supports expanded clinical trials using this intervention
CELZ TRIAL AT UCLA DD & EXPLANATION: DD
Creative Medical Health, Inc. announced that the first patient has been enrolled in the Caverstem® Clinical Trial to Evaluate the Safety and Efficacy of Intra-cavernosal Administration of Non-Expanded Autologous Bone Marrow Cells in Treatment of Erectile Dysfunction .
Caverstem® Study Objective
To evaluate safety and efficacy of autologous bone marrow mononuclear cells concentrated using a closed-system device, the Arteriocyte Magellan® device, and injected intra-cavernously in 20 patients aged 18 to 40 years of age diagnosed with erectile dysfunction. Safety will be determined based on device- and procedure-associated adverse events and blood chemistry measurements at baseline vs. follow up visits at one, three, six, and twelve months post-treatment. Efficacy will be evaluated at baseline and follow up visits by Doppler ultrasound, dynamic infusion cavernosometry, and blood work. The study will determine whether injection of bone marrow cells intra-cavernously is a clinically feasible therapeutic approach for treating erectile dysfunction.
Caverstem® Study Location
The Caverstem® trial being conducted by Dr. Jacob Rajfer and the LA Biomed research team at UCLA / Harbor Medical Center located in Torrance, California.
About Caverstem®
Creative Medical Health, Inc. owns U.S. patent #20,090,311,223, titled “Treatment of Erectile Dysfunction by Stem Cell Therapy,” which covers the use of various stem cells for treatment of patients who do not respond to Viagra, Cialis and Levitra. In contrast to pharmaceutical agents, the Caverstem® treatment developed by Creative Medical Health, Inc. involves regenerating the blood vessels and smooth muscle of the penis, thus offering the possibility of permanent regeneration, not a temporary remedy.
The medical procedure involves extracting stem cells from the patient’s own bone marrow, processing them and subsequent administration into the penis. A peer-reviewed study describing the first patient treated with this procedure may be found at http://www.translational-medicine.com/content/pdf/1479-5876-11-139.pdf.
“There are approximately 30 million patients with erectile dysfunction in the USA. Of these, 30% do not respond to pharmaceutical interventions, which represents approximately 9 million potential patients that could benefit from our approach,” stated Timothy Warbington, CEO of Creative Medical Health, Inc. “Given that this patient group has limited alternatives besides costly implants and injections before intercourse, which can be associated with horrific side effects, we believe it is our responsibility to accelerate development of this program in a timely manner.”
The use of bone marrow stem cells is currently part of medical practice in bone marrow transplantation, and is currently in advanced clinical trials for conditions including heart failure, peripheral artery disease and stroke. Creative Medical Health, Inc. is the first to patent and subsequently clinically validate the feasibility of applying this form of stem cell therapy to urological conditions.
WOW - This is why we are heading to a dollar. https://seekingalpha.com/filing/3403266
Great DD here. Read >>>> “Prior to the closing of the Patent Purchase Agreement, CMH was in the process of commencing clinical trial studies on the efficacy and safety of the ED stem cell treatment. As a result of the purchase of the ED patent by us, we have now taken over the clinical trial studies. After the trial is completed, and if the data supports the treatment, we intend to market the technology with complete kits and training to medical doctors, who can practice the treatment for their patients.”
THIS WILL CLOSE ABOVE .02 TODAY. Possibly news next week I bet!!!! WATCH IT RUN HERE.
Shorting TARDS!!!!!! These losers have no control over the highly talented management team, all of the patents, all of the stem cell technology, all of The doctors that will be signing up, all of the potential revenues and current revenue flowing in, and most importantly, all of the individuals who will benefit from some degree from this company. They can do their thing here but they are downright nervous and they should be!!!! THEY BETTER BE!!!!!! Frig me. They will help us ultimately get to a nickel. This is not a company too short. HAVE AT IT LOSERS!!!!!!!
This may touch .01 today. Going to run here. Great DD ROOM! I personally holding out for a nickel. Why? Because the deal, the amalgamation, and the potential revenue dictates that price point. Do your own DD here.
I strongly think the news will be bigger than we think. I see this heading right to a penny and hitting .011 before it typically falls back to .008 level. Let’s see. Lots of eyes on this low float - high riser stock. Get your ticket in the a.m!!! Playboy club financing what?? Woohoo
GREAT GORGE PLAYBOY CLUB NEWS IMMINENT!!!!! Massive realestate deal happening here you guys!! Do your DD. This is going to put this company on the map. Wait until they start to extinguish some of their shares from the float! This has the potential to be a multi bagger no doubt. We will not see these Low’s again. Shorts are going to need to cover here like today and onward. It’s actually the shorts that are going to drive this up along with new investors finding out about this company. More going on here behind the scenes than we realize. The news will start to flow and this ..... this co. is going to look a lot different here. Use wisdom and investigative skills before you buy. Intelligent investors are getting in at these levels. Anything below a penny is the complete gift IMHO.
Dr. Jacob Rajfer is a top Urologist who ran the trial for Caverstem!!!! Huge vote of confidence I would say
Professional Memberships
American Fertility Society
Kidney Foundation of Southern California
Society for the Study of Reproduction
Los Angeles Urological Society
Southern California Transplant Society
Society of University Urologists
Pacific Coast Fertility Society
Western Section, American Urological Association, Inc.
UCLA Jonsson Comprehensive Cancer Center
American College of Surgeons - Fellow
American Urological Association
American Society of Andrology
Urologic Society for Transplantation and Vascular Surgery
California Urological Society
Western Association of Transplant Surgeons
The Endocrine Society
American Society of Transplant Surgeons
Society for the Study of Impotence
Society of Pediatric Urology
Western Urologic Forum
American Academy of Pediatric
Academic & Medical Staff Appointments
Professor, Division of Urology, Department of Surgery, University of California at Los Angeles, Los Angeles, California, 1989 to present
Associate Professor, Division of Urology, Department of Surgery, University of California at Los Angeles, Los Angeles, California, 1983-89
Assistant Professor, Division of Urology, Department of Surgery, University of California at Los Angeles, Los Angeles, California, 1980-83
Assistant Professor, Department of Urology, University of Washington, Seattle, Washington, 1978-80
Links
urology.ucla.edu
Exactly. This will get fun. I love it when all the idiots that have been shorting this have to cover. We will be at two cents in a matter of time. It’s the content of the news that will help. This is what we have been waiting for and the company has sure been quiet. Enjoy the ride
This is heading to .0068 tomorrow. Market makers have been told. Hold tight you guys. Something is coming down the PR pipe! DEAL IS DONE! This company is going to look quite different here over the next month. Shorts will need to cover here now. However, sit back and watch. Mark this post.
Anything below two cents is a gift. This thing is going to launch and be all the talk here on I hub. Looking forward to hearing how many doctors they signed up. I’ll bet you they got 25 by now. They have been actively recruiting and I believe things are going extremely well. The doctor says so.
Selling at this level is insane. You will be leaving a lot of money on the table! Hold and thank me later!!!!!! Mark this post.
Three things that help me sleep at night and make me believe this will run to $1.50. Here they are: 1) DR. ICHIM 2) DR. GERSHMAN 3) MEDISTEM TRACK RECORD + TIM WARBINGTON!!!!!!!!!!!!!!!!!!!!!!!! Now re-read this post a few times. I think you see what I am trying to say here. $1.50 is coming!!!!!!!!
Think Hong Kong + China!!!!!!!!!!!! From what I understand, the company is open to the idea of bringing urologists over from these countries to introduce them to the patented procedure. The amount of men in those countries suffering from ED are astronomical. This is going to get really funky.
When the share price moves up .0001 at a time, people get all excited. Turn your computer is off and come back and Christmas time. You will be able to take your family to the moon And still have enough to pay off your mortgage and all your credit cards!!. Oh yeah, and the loan you have out from your dad that you still haven’t paid off! TURN YOUR COMPUTER OFF!!!! $2.50 by January 2019. Oh yeah, and by then, the company will have retired millions of shares. That will be in a separate press release. Big Hollywood names coming on board. Medistem alllllllll over again. YIPPPPEEEE
This will be .03 cents by Friday. Mark this post!! Because >>>> The world is slowly finding out about this Patented procedure. Keyword patent(S). Dr Ichim et al - all rock!!!! The next press release, I bet, will say something about how great the conference was in San Francisco and how many doctors they have signed up. The next Paragraph will be something about the response they have gotten from not only the medical community but from individuals suffering from ED. This whole thing is going to be a moneymaking machine. You have to admit, the people involved, the management, are all outstanding individuals who would not want to tarnish there Their reputations. I’m expecting by December of this year, we could very well be at $2.50. Others have run similar to this. This thing is about to rocket and you better have a ticket or you will regret it - BIG TIME!!
If these 4 links don’t give you a chubby, nothing will. This is why the stock is going to run huge.
https://finance.yahoo.com/news/medistem-inc-annual-letter-shareholders-101724022.html
https://www.nasdaq.com/markets/spos/company/medistem-inc-378678-51618
https://www.advfn.com/stock-market/USOTC/MEDS/financials
https://www.prnewswire.com/news-releases/intrexon-to-acquire-medistem-to-generate-multipotent-cells-236709961.html
If these 4 links don’t give you a chubby, nothing will. This is why the stock is going to run huge.
https://finance.yahoo.com/news/medistem-inc-annual-letter-shareholders-101724022.html
https://www.nasdaq.com/markets/spos/company/medistem-inc-378678-51618
https://www.advfn.com/stock-market/USOTC/MEDS/financials
https://www.prnewswire.com/news-releases/intrexon-to-acquire-medistem-to-generate-multipotent-cells-236709961.html
If these 4 links don’t give you a chubby, nothing will. This is why the stock is going to run huge.
https://finance.yahoo.com/news/medistem-inc-annual-letter-shareholders-101724022.html
https://www.nasdaq.com/markets/spos/company/medistem-inc-378678-51618
https://www.advfn.com/stock-market/USOTC/MEDS/financials
https://www.prnewswire.com/news-releases/intrexon-to-acquire-medistem-to-generate-multipotent-cells-236709961.html
I just bought in on Friday. You guys are sure busy in here. Just signed up. I’m a firm believer that we are going to really do well here. So much in the pipe and these are really top management people. As it was said here, a lot of the shares are held by insiders. Things are ramping up in Los Angeles I can tell you that.
I can also tell you that Dr. ICHIM (author of patent - CaverStem) is well known at the FDA. He has dealt with them on numerous occasions. Probably the only reason I’m involved here in this stock is because of him! Family friend but I only met him once like five years ago. Need I say more. From my Dd . This thing is heading right to $.15 faster than we think. Look at the chart, do a six-month on it and you will see what I mean. This is happened many times on these markets.
These guys are going to sign up doctors like crazy. There are many of these mom and pop stem cell shop set up in North America and the FDA is aware of it. THIS IS DIFFERENT!!! The FDA likes companies that have cell-based products that are Hematopoietic progenitor cell based. The machines as we know them, are FDA approved. The cats are FDA approved as well. However the procedure is exempt from compliance with any additional FDA rules under the code of federal regulations. They state “, you are not required to comply with the requirements of this part if you are an establishment that removes HCT/P’s from an individual and implant such HCT/P’s into the same individual during the same surgical procedure”. Oh ya baby!!!
Dr. Ichim has taken several other cell therapies to the FDA for clearance and for clinical trials. Tim Warmington knows exactly what he’s doing. These guys ran a stock way north some years ago. This is going to be a carbon copy. As far as I’m concerned, you are being gifted if you get in below two cents which I doubt will last very long.
Ok, back to golfing.